Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy (Q37008814)

17 August 2017

1 reference

title

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy (English)

1 reference

17 August 2017

1 reference

2

Pierluigi Viale

1 reference

17 August 2017

4

Mario Furlanut

1 reference

17 August 2017

3

Federica Pavan

1 reference

17 August 2017

Federico Pea

1

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Clinical Pharmacokinetics

17 August 2017

published in

1 reference

17 August 2017

volume

46

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

997-1038

1 reference

Extravascular penetration of highly protein-bound flucloxacillin

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Multiple-dose ciprofloxacin dose ranging and kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of ofloxacin after parenteral and oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F00003088-200746120-00003

21 January 2018

12 December 2020

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans

1 reference

12 December 2020

Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients

1 reference

12 December 2020

A pilot study of netilmicin pharmacokinetics during continuous venovenous hemodiafiltration

1 reference

12 December 2020

Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration

1 reference

12 December 2020

Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients

1 reference

12 December 2020

Linezolid clearance during continuous venovenous hemodiafiltration: a case report

1 reference

12 December 2020

Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients

1 reference

12 December 2020

Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study

1 reference

12 December 2020

Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing

1 reference

12 December 2020

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

1 reference

12 December 2020

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.

1 reference

12 December 2020

Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure

1 reference

12 December 2020

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

1 reference

12 December 2020

Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients

1 reference

12 December 2020

Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure

1 reference

12 December 2020

Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH)

1 reference

12 December 2020

Drug dosing adjustments during continuous renal replacement therapies

1 reference

12 December 2020

Overview of the lipid formulations of amphotericin B.

1 reference

12 December 2020

Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration

1 reference

12 December 2020

Cefpirome and continuous venovenous hemofiltration

1 reference

12 December 2020

Clearance of linezolid via continuous venovenous hemodiafiltration

1 reference

12 December 2020

Clinical pharmacokinetics of teicoplanin

1 reference

12 December 2020

Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects

1 reference

12 December 2020

Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration

1 reference

12 December 2020

Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

1 reference

12 December 2020

Continuous renal replacement therapy in critically ill patients

1 reference

12 December 2020

Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis

1 reference

12 December 2020

Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

1 reference

12 December 2020

Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration

1 reference

12 December 2020

Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure

1 reference

12 December 2020

Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration

1 reference

12 December 2020

The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration

1 reference

12 December 2020

Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies.

1 reference

12 December 2020

The clinical pharmacokinetics of levofloxacin

1 reference

12 December 2020

Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

1 reference

12 December 2020

Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration

1 reference

12 December 2020

Linezolid and continuous venovenous hemofiltration

1 reference

12 December 2020

Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients

1 reference

12 December 2020

Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution

1 reference

12 December 2020

Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration

1 reference

12 December 2020

Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration

1 reference

12 December 2020

Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis

1 reference

12 December 2020

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens

1 reference

12 December 2020

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

1 reference

12 December 2020

Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration

1 reference

12 December 2020

Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient

1 reference

12 December 2020

Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration

1 reference

12 December 2020

Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration

1 reference

12 December 2020

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients

1 reference

12 December 2020

Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval

1 reference

12 December 2020

Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.

1 reference

12 December 2020

Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration

1 reference

12 December 2020

Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration

1 reference

12 December 2020

A primer on continuous renal replacement therapy for critically ill patients

1 reference

12 December 2020

Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

1 reference

12 December 2020

Pharmacokinetics of fluconazole in normal volunteers

1 reference

12 December 2020

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

12 December 2020

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

1 reference

12 December 2020

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

1 reference

12 December 2020

Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients

1 reference

12 December 2020

The pharmacokinetics of ceftazidime during hemodiafiltration in critically ill patients

1 reference

12 December 2020

Continuous hemofiltration/hemodiafiltration in critical care

1 reference

12 December 2020

Comparative pharmacokinetics of the carbapenems: clinical implications

1 reference

12 December 2020

Multicompartment pharmacokinetics of netilmicin

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

1 reference

12 December 2020

Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors

1 reference

12 December 2020

Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective

1 reference

12 December 2020

Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD)

1 reference

12 December 2020

Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

1 reference

12 December 2020

Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration

1 reference

12 December 2020

Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration

1 reference

12 December 2020

Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases

1 reference

12 December 2020

Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients

1 reference

12 December 2020

How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin

1 reference

12 December 2020

1 reference

12 December 2020

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

1 reference

12 December 2020

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

1 reference

12 December 2020

10.2165/00003088-200746120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1037046770

0 references

Fatcat ID

release_iuuxidqmgfdlnigrfx2r2kcctm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iuuxidqmgfdlnigrfx2r2kcctm

24 November 2022

mapped directly with Wikidata item

1 reference